Worldwide Clinical Trials

Worldwide Clinical Trials is a global Contract Research Organization (CRO) providing clinical trial services across all phases of drug development, from Phase I clinical pharmacology through Phase IV and post-approval studies. The company has been in operation for more than 30 years and employs over 3,500 clinicians, scientists, and researchers working on clinical research, clinical pharmacology, and clinical trial operations worldwide.

Work is organised around therapeutically aligned teams rather than generalist units. These dedicated groups specialise in six areas: rare diseases, cardiovascular and metabolic conditions, cell and gene therapy, oncology, neuroscience, and immune-mediated inflammatory diseases. Services span Phase II-III clinical trial delivery, early-phase clinical pharmacology, and late-phase and post-approval studies, with senior-level experts working directly with clients on solutions tailored to each trial rather than off-the-shelf packages.

The stated culture emphasises scientific knowledge and operational excellence, and an appetite for complex programmes over straightforward ones. The company describes its aim as bringing clarity to complex drug development for patients, and its working ethos as mission-driven, with an explicit rejection of a cautious, play-it-safe approach to research. Positions are suited to clinicians, scientists, and researchers interested in therapeutic-area specialisation within pharmaceuticals, biotechnology, and clinical research.